PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
17.22%
Revenue growth 1.25-1.5x QCOM's 12.14%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
31.76%
Gross profit growth above 1.5x QCOM's 10.02%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
80.61%
EBIT growth below 50% of QCOM's 9040.00%. Michael Burry would suspect deeper competitive or cost structure issues.
122.45%
Operating income growth under 50% of QCOM's 9040.00%. Michael Burry would be concerned about deeper cost or sales issues.
106.92%
Net income growth under 50% of QCOM's 355.02%. Michael Burry would suspect the firm is falling well behind a key competitor.
104.76%
EPS growth under 50% of QCOM's 350.00%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
110.00%
Diluted EPS growth under 50% of QCOM's 344.44%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.95%
Share reduction while QCOM is at 0.30%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.31%
Reduced diluted shares while QCOM is at 1.45%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
0.23%
Maintaining or increasing dividends while QCOM cut them. John Neff might see a strong edge in shareholder returns.
49.73%
Positive OCF growth while QCOM is negative. John Neff would see this as a clear operational advantage vs. the competitor.
19.45%
Positive FCF growth while QCOM is negative. John Neff would see a strong competitive edge in net cash generation.
61.72%
10Y revenue/share CAGR at 50-75% of QCOM's 99.07%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
22.16%
5Y revenue/share CAGR under 50% of QCOM's 101.12%. Michael Burry would suspect a significant competitive gap or product weakness.
-8.11%
Negative 3Y CAGR while QCOM stands at 42.73%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
110.74%
10Y OCF/share CAGR under 50% of QCOM's 446.08%. Michael Burry would worry about a persistent underperformance in cash creation.
22.04%
Below 50% of QCOM's 140.76%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
138.85%
3Y OCF/share CAGR above 1.5x QCOM's 34.74%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
79.23%
Below 50% of QCOM's 807.73%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
31.73%
5Y net income/share CAGR at 50-75% of QCOM's 48.38%. Martin Whitman might see a shortfall in operational efficiency or brand power.
-8.03%
Negative 3Y CAGR while QCOM is 15.93%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
59.53%
Below 50% of QCOM's 863.98%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
0.89%
Below 50% of QCOM's 100.46%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
-5.83%
Negative 3Y equity/share growth while QCOM is at 45.60%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
460.05%
Dividend/share CAGR of 460.05% while QCOM is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
428.42%
5Y dividend/share CAGR above 1.5x QCOM's 240.39%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
260.00%
3Y dividend/share CAGR above 1.5x QCOM's 41.21%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
15.35%
AR growth well above QCOM's 17.29%. Michael Burry fears inflated revenue or higher default risk in the near future.
4.99%
We show growth while QCOM is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
3.41%
Asset growth at 50-75% of QCOM's 6.76%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
3.42%
Under 50% of QCOM's 9.01%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
No Data
No Data available this quarter, please select a different quarter.
-0.27%
Our R&D shrinks while QCOM invests at 2.32%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
3.98%
SG&A growth well above QCOM's 0.53%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.